Role of dendritic cells in MYD88-mediated immune recognition and osteoinduction initiated by the implantation of biomaterials
(
), Yuchun Sun1()Abstract
Bone substitute material implantation has become an important treatment strategy for the repair of oral and maxillofacial bone defects. Recent studies have shown that appropriate inflammatory and immune cells are essential factors in the process of osteoinduction of bone substitute materials. Previous studies have mainly focused on innate immune cells such as macrophages. In our previous work, we found that T lymphocytes, as adaptive immune cells, are also essential in the osteoinduction procedure. As the most important antigen-presenting cell, whether dendritic cells (DCs) can recognize non-antigen biomaterials and participate in osteoinduction was still unclear. In this study, we found that surgical trauma associated with materials implantation induces necrocytosis, and this causes the release of high mobility group protein-1 (HMGB1), which is adsorbed on the surface of bone substitute materials. Subsequently, HMGB1-adsorbed materials were recognized by the TLR4-MYD88-NFκB signal axis of dendritic cells, and the inflammatory response was activated. Finally, activated DCs release regeneration-related chemokines, recruit mesenchymal stem cells, and initiate the osteoinduction process. This study sheds light on the immune-regeneration process after bone substitute materials implantation, points out a potential direction for the development of bone substitute materials, and provides guidance for the development of clinical surgical methods.
References
Lee, J., Byun, H., Madhurakkat Perikamana, S. K., Lee, S. & Shin, H. Current advances in immunomodulatory biomaterials for bone regeneration. Adv. Healthc. Mater. 8, e1801106 (2019).
Pina, S., Oliveira, J. M. & Reis, R. L. Natural-based nanocomposites for bone tissue engineering and regenerative medicine: a review. Adv. Mater 27, 1143–1169 (2015).
Tsukasaki, M. & Takayanagi, H. Osteoimmunology: evolving concepts in bone-immune interactions in health and disease. Nat. Rev. Immunol. 19, 626–642 (2019).
Walsh, M. C., Takegahara, N., Kim, H. & Choi, Y. Updating osteoimmunology: regulation of bone cells by innate and adaptive immunity. Nat. Rev. Rheumatol. 14, 146–156 (2018).
Pajarinen, J. et al. Mesenchymal stem cell-macrophage crosstalk and bone healing. Biomaterials 196, 80–89 (2019).
Spiller, K. L. et al. Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds. Biomaterials 37, 194–207 (2015).
Yin, C. et al. Biomimetic anti-inflammatory nano-capsule serves as a cytokine blocker and M2 polarization inducer for bone tissue repair. Acta Biomater. 102, 416–426 (2020).
Zhao, Q. et al. Dual-wavelength photosensitive nano-in-micro scaffold regulates innate and adaptive immune responses for osteogenesis. Nanomicro Lett. 13, 28 (2020).
Yin, C. et al. Transcription factor 7-like 2 promotes osteogenic differentiation and boron-induced bone repair via lipocalin 2. Mater. Sci. Eng. C Mater. Biol. Appl. 110, 110671 (2020).
Brown, B. N., Haschak, M. J., Lopresti, S. T. & Stahl, E. C. Effects of age-related shifts in cellular function and local microenvironment upon the innate immune response to implants. Semin. Immunol. 29, 24–32 (2017).
Chung, L., Maestas, D. R. Jr., Housseau, F. & Elisseeff, J. H. Key players in the immune response to biomaterial scaffolds for regenerative medicine. Adv. Drug. Deliv. Rev. 114, 184–192 (2017).
Zhao, Z. et al. Minimally invasive implantation and decreased inflammation reduce osteoinduction of biomaterial. Theranostics 10, 3533–3545 (2020).
Takayanagi, H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7, 292–304 (2007).
Walschus, U. et al. Morphometric immunohistochemical examination of the inflammatory tissue reaction after implantation of calcium phosphate-coated titanium plates in rats. Acta Biomater. 5, 776–784 (2009).
Qi, K., Li, N., Zhang, Z. & Melino, G. Tissue regeneration: the crosstalk between mesenchymal stem cells and immune response. Cell Immunol. 326, 86–93 (2018).
Liu, H., Li, D., Zhang, Y. & Li, M. Inflammation, mesenchymal stem cells and bone regeneration. Histochem. Cell Biol. 149, 393–404 (2018).
Yang, R. N. et al. Osteoinduction by Ca-P biomaterials implanted into the muscles of mice. J. Zhejiang Univ. Sci. B 12, 582–590 (2011).
Shi, M. et al. Inorganic self-assembled bioactive artificial proto-osteocells inducing bone regeneration. ACS Appl. Mater. Interfaces 10, 10718–10728 (2018).
Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C. & Amigorena, S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20, 621–667 (2002).
Sabado, R. L., Balan, S. & Bhardwaj, N. Dendritic cell-based immunotherapy. Cell Res. 27, 74–95 (2017).
Kohri, M., Miki, K., Waite, D. E., Nakajima, H. & Okabe, T. In vitro stability of biphasic calcium phosphate ceramics. Biomaterials 14, 299–304 (1993).
Bouler, J. M., Pilet, P., Gauthier, O. & Verron, E. Biphasic calcium phosphate ceramics for bone reconstruction: a review of biological response. Acta Biomater. 53, 1–12 (2017).
Sanchez-Paulete, A. R. et al. Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy. Ann. Oncol. 28, xii44–xii55 (2017).
Lindenbergh, M. F. S. & Stoorvogel, W. Antigen presentation by extracellular vesicles from professional antigen-presenting cells. Annu. Rev. Immunol. 36, 435–459 (2018).
Bianchi, M. E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1–5 (2007).
Sancho, D. et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 458, 899–903 (2009).
Kang, R. et al. HMGB1 in health and disease. Mol. Aspects Med. 40, 1–116 (2014).
Andersson, U. & Tracey, K. J. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 29, 139–162 (2011).
Hirsiger, S., Simmen, H. P., Werner, C. M., Wanner, G. A. & Rittirsch, D. Danger signals activating the immune response after trauma. Mediators Inflamm. 2012, 315941 (2012).
Goligorsky, M. S. TLR4 and HMGB1: partners in crime? Kidney Int. 80, 450–452 (2011).
Andersson, U., Yang, H. & Harris, H. Extracellular HMGB1 as a therapeutic target in inflammatory diseases. Expert Opin. Ther. Targets 22, 263–277 (2018).
Chen, X. et al. Correlations between macrophage polarization and osteoinduction of porous calcium phosphate ceramics. Acta Biomater. 103, 318–332 (2020).
Davison, N. L. et al. Influence of surface microstructure and chemistry on osteoinduction and osteoclastogenesis by biphasic calcium phosphate discs. Eur. Cell Mater. 29, 314–329 (2015).
Chen, Z. et al. Nanoporous microstructures mediate osteogenesis by modulating the osteo-immune response of macrophages. Nanoscale 9, 706–718 (2017).
Alnaeeli, M. & Teng, Y. T. Dendritic cells: a new player in osteoimmunology. Curr. Mol. Med. 9, 893–910 (2009).
Silva, A. M. et al. Dendritic cell-derived extracellular vesicles mediate mesenchymal stem/stromal cell recruitment. Sci. Rep. 7, 1667 (2017).
Bennett, C. L. & Clausen, B. E. DC ablation in mice: promises, pitfalls, and challenges. Trends Immunol. 28, 525–531 (2007).
van Rijt, L. S. et al. House dust mite allergic airway inflammation facilitates neosensitization to inhaled allergen in mice. Allergy 67, 1383–1391 (2012).
Tittel, A. P. et al. Functionally relevant neutrophilia in CD11c diphtheria toxin receptor transgenic mice. Nat. Methods 9, 385–390 (2012).
Steinman, R. M. Decisions about dendritic cells: past, present, and future. Annu. Rev. Immunol. 30, 1–22 (2012).
Geissmann, F. et al. Development of monocytes, macrophages, and dendritic cells. Science 327, 656–661 (2010).
Pulendran, B., Tang, H. & Denning, T. L. Division of labor, plasticity, and crosstalk between dendritic cell subsets. Curr. Opin. Immunol. 20, 61–67 (2008).
Neyt, K. & Lambrecht, B. N. The role of lung dendritic cell subsets in immunity to respiratory viruses. Immunol. Rev. 255, 57–67 (2013).
Lord, J. M. et al. The systemic immune response to trauma: an overview of pathophysiology and treatment. Lancet 384, 1455–1465 (2014).
Visalakshan, R. M. et al. Biomaterial surface hydrophobicity-mediated serum protein adsorption and immune responses. ACS Appl. Mater. Interfaces 11, 27615–27623 (2019).
Hotchkiss, K. M., Clark, N. M. & Olivares-Navarrete, R. Macrophage response to hydrophilic biomaterials regulates MSC recruitment and T-helper cell populations. Biomaterials 182, 202–215 (2018).
LeGeros, R. Z. Biodegradation and bioresorption of calcium phosphate ceramics. Clin. Mater. 14, 65–88 (1993).
Sheikh, Z. et al. Mechanisms of in vivo degradation and resorption of calcium phosphate based biomaterials. Materials 8, 7913–7925 (2015).
Chen, Z. et al. Nanotopography-based strategy for the precise manipulation of osteoimmunomodulation in bone regeneration. Nanoscale 9, 18129–18152 (2017).
Tostanoski, L. H. & Jewell, C. M. Engineering self-assembled materials to study and direct immune function. Adv. Drug. Deliv. Rev. 114, 60–78 (2017).
Bortolotti, P., Faure, E. & Kipnis, E. Inflammasomes in tissue damages and immune disorders after trauma. Front. Immunol. 9, 1900 (2018).
Rock, K. L. & Kono, H. The inflammatory response to cell death. Annu. Rev. Pathol. 3, 99–126 (2008).
Park, J. & Babensee, J. E. Differential functional effects of biomaterials on dendritic cell maturation. Acta Biomater. 8, 3606–3617 (2012).
Gougeon, M. L., Melki, M. T. & Saidi, H. HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells. Cell Death Differ. 19, 96–106 (2012).
Fang, H. et al. TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells. Cell Mol. Immunol. 11, 150–159 (2014).
Kariko, K., Buckstein, M., Ni, H. & Weissman, D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165–175 (2005).
Hemmi, H., Kaisho, T., Takeda, K. & Akira, S. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J. Immunol. 170, 3059–3064 (2003).
Gao, Q. et al. A cycle involving HMGB1, IFN-gamma and dendritic cells plays a putative role in anti-tumor immunity. Cell Immunol. 343, 103850 (2019).
Krysko, D. V. et al. Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer 12, 860–875 (2012).
Yang, H. et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc. Natl Acad. Sci. USA 107, 11942–11947 (2010).
Zelenay, S. & Reis e Sousa, C. Adaptive immunity after cell death. Trends Immunol. 34, 329–335 (2013).
Jiang, M. et al. Alterations of DNA damage response pathway: biomarker and therapeutic strategy for cancer immunotherapy. Acta Pharm. Sin B 11, 2983–2994 (2021).
Liu, Y., Yin, H., Zhao, M. & Lu, Q. TLR2 and TLR4 in autoimmune diseases: a comprehensive review. Clin. Rev. Allergy Immunol. 47, 136–147 (2014).
Jiang, J. Y., Liu, D. J. & Liu, M. X. The protective effect of NF-kappaB signaling pathway inhibitor PDTC on mice with chronic atrophic gastritis. Scand. J. Gastroenterol. 56, 1131–1139 (2021).
Deguine, J. & Barton, G. M. MyD88: a central player in innate immune signaling. F1000Prime Rep. 6, 97 (2014).
Shi, Y. J. et al. Toll-like receptor 4 (TLR4) deficiency aggravates dextran sulfate sodium (DSS)-induced intestinal injury by down-regulating IL6, CCL2 and CSF3. Ann. Transl. Med. 7, 713 (2019).
Jin, S. et al. Function of astrocyte MyD88 in high-fat-diet-induced hypothalamic inflammation. J Neuroinflammation 17, 195 (2020).
Zhu, X. et al. MyD88 signalling is critical in the development of pancreatic cancer cachexia. J. Cachexia Sarcopenia Muscle 10, 378–390 (2019).
Anderson, J. M., Rodriguez, A. & Chang, D. T. Foreign body reaction to biomaterials. Semin. Immunol. 20, 86–100 (2008).
Omar, O. M. et al. The stimulation of an osteogenic response by classical monocyte activation. Biomaterials 32, 8190–8204 (2011).
Lee, C. H. et al. Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study. Lancet 376, 440–448 (2010).
Son, M. H., Jung, M. Y., Choi, S., Cho, D. & Kim, T. S. IL-32gamma induces chemotaxis of activated T cells via dendritic cell-derived CCL5. Biochem. Biophys. Res. Commun. 450, 30–35 (2014).
Babensee, J. E. Interaction of dendritic cells with biomaterials. Semin. Immunol. 20, 101–108 (2008).
Wang, S. et al. The role of dendritic cells in the immunomodulation to implanted biomaterials. Int. J. Oral Sci. 14, 52 (2022).
Wang, J. et al. CD301b(+) macrophages mediate angiogenesis of calcium phosphate bioceramics by CaN/NFATc1/VEGF axis. Bioact. Mater. 15, 446–455 (2022).
Zhang, J. et al. Sustained calcium ion release from bioceramics promotes CaSR-mediated M2 macrophage polarization for osteoinduction. J. Leukoc. Biol. 110, 485–496 (2021).
京公网安备11010802044758号